pqq cofactor has been researched along with Idiopathic Parkinson Disease in 4 studies
PQQ Cofactor: A pyrrolo-quinoline having two adjacent keto-groups at the 4 and 5 positions and three acidic carboxyl groups. It is a coenzyme of some DEHYDROGENASES.
pyrroloquinoline quinone : A pyrroloquinoline having oxo groups at the 4- and 5-positions and carboxy groups at the 2-, 7- and 9-positions.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 2 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, S | 2 |
| Raja, A | 1 |
| Noroozifar, M | 2 |
| Kerman, K | 2 |
| Zhou, J | 1 |
| Ng, CH | 1 |
| Basil, AH | 1 |
| Hang, L | 1 |
| Tan, R | 1 |
| Goh, KL | 1 |
| O'Neill, S | 1 |
| Zhang, X | 1 |
| Yu, F | 1 |
| Lim, KL | 1 |
| Zhang, Q | 1 |
| Chen, S | 1 |
| Yu, S | 1 |
| Qin, J | 1 |
| Zhang, J | 1 |
| Cheng, Q | 1 |
| Ke, K | 1 |
| Ding, F | 1 |
4 other studies available for pqq cofactor and Idiopathic Parkinson Disease
| Article | Year |
|---|---|
Understanding the Inhibitory and Antioxidant Effects of Pyrroloquinoline Quinone (PQQ) on Copper(II)-Induced α-Synuclein-119 Aggregation.
Topics: alpha-Synuclein; Antioxidants; Copper; Dopaminergic Neurons; Humans; Parkinson Disease; PQQ Cofactor | 2022 |
Electrochemical flow injection analysis of the interaction between pyrroloquinoline quinone (PQQ) and α-synuclein peptides related to Parkinson's disease.
Topics: alpha-Synuclein; Flow Injection Analysis; Humans; Parkinson Disease; Peptides; PQQ Cofactor | 2021 |
Genetic or pharmacological activation of the Drosophila PGC-1α ortholog spargel rescues the disease phenotypes of genetic models of Parkinson's disease.
Topics: AMP-Activated Protein Kinases; Animals; Disease Models, Animal; Drosophila; Drosophila Proteins; Gen | 2017 |
Neuroprotective effects of pyrroloquinoline quinone against rotenone injury in primary cultured midbrain neurons and in a rat model of Parkinson's disease.
Topics: Animals; Cell Line, Tumor; Cells, Cultured; Dose-Response Relationship, Drug; Humans; Mesencephalon; | 2016 |